SYNLAB AGSYNLAB AGSYNLAB AG

SYNLAB AG

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪2.29 B‬CHF
‪85.75 M‬CHF
‪2.45 B‬CHF
‪31.24 M‬
Beta (1Y)
0.24

About SYNLAB AG

CEO
Mathieu Olivier Floreani
Website
Headquarters
Munich
Employees (FY)
‪27.05 K‬
Founded
2019
ISIN
DE000A2TSL71
FIGI
BBG011R5HCS0
Synlab AG engages in the provision of clinical laboratory and medical diagnostic services. The firm offers medical diagnostic information for patients, practicing doctors, clinics, and the pharmaceutical industry. It operates through the following geographical segments: France, Germany, South Region, and North and East Regions. The company was founded by Bartholomaeus Wimmer in 1998 and is headquartered in Munich, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SYAB is 7.842 CHF — it has decreased by 28.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange SYNLAB AG stocks are traded under the ticker SYAB.
SYNLAB AG is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
SYAB stock is 39.17% volatile and has beta coefficient of 0.24. Check out the list of the most volatile stocks — is SYNLAB AG there?
SYAB earnings for the last quarter are −0.06 CHF per share, whereas the estimation was 0.11 CHF resulting in a −154.55% surprise. The estimated earnings for the next quarter are 0.11 CHF per share. See more details about SYNLAB AG earnings.
SYNLAB AG revenue for the last quarter amounts to ‪675.52 M‬ CHF despite the estimated figure of ‪618.41 M‬ CHF. In the next quarter revenue is expected to reach ‪667.97 M‬ CHF.
Yes, you can track SYNLAB AG financials in yearly and quarterly reports right on TradingView.
SYAB stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in SYNLAB AG price.
SYAB net income for the last quarter is ‪−71.72 M‬ CHF, while the quarter before that showed ‪125.30 M‬ CHF of net income which accounts for −157.24% change. Track more SYNLAB AG financial stats to get the full picture.
Today SYNLAB AG has the market capitalization of ‪2.27 B‬, it has increased by 2.34% over the last week.
Yes, SYAB dividends are paid annually. The last dividend per share was 0.32 CHF. As of today, Dividend Yield (TTM)% is 3.14%. Tracking SYNLAB AG dividends might help you take more informed decisions.
Like other stocks, SYAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNLAB AG stock right from TradingView charts — choose your broker and connect to your account.
SYAB reached its all-time high on Jan 5, 2023 with the price of 10.914 CHF, and its all-time low was 7.842 CHF and was reached on Feb 7, 2023.
See other stocks reaching their highest and lowest prices.
As of May 1, 2024, the company has ‪27.05 K‬ employees. See our rating of the largest employees — is SYNLAB AG on this list?
We've gathered analysts' opinions on SYNLAB AG future price: according to them, SYAB price has a max estimate of 9.78 CHF and a min estimate of 9.78 CHF. Read a more detailed SYNLAB AG forecast: see what analysts think of SYNLAB AG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNLAB AG EBITDA is ‪392.87 M‬ CHF, and current EBITDA margin is 15.61%. See more stats in SYNLAB AG financial statements.